ESR1 and breast cancer: The metabolic enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is overexpressed in BC [149], and activates src-3, which in turn activates the estrogen receptor (ER) [150].